Moreover, reservoirs of latently infected resting memory CD4+ T lymphocytes are established early after infection and persist throughout treatment with exceedingly slow decay rates; these latent reservoirs are unlikely to be eliminated by HAART alone, and thus have the potential to re-ignite the infection if activated after therapy is halted. This evidence concerns the gene CD4 and infection.